Derived from proteins made by the body’s immune system, monoclonal antibodies are successful drugs used to treat millions of patients. The MRC/UCB Antibody Discovery Initiative offers academic researchers access to UCB’s high-tech antibody discovery platform. Andrew Popplewell, Head of Antibody Discovery and Engineering at UCB Celltech, explains how the initiative is geared to help promote collaborative research.
Image credit: Andrew Popplewell.
In the pharmaceutical and biotechnology industry today, collaboration and networking are all-important. And the value of tapping into academic knowledge, expertise, and talent is widely acknowledged.
Starting university should be a time for having fun and making new friends. So why are we seeing record referral rates to student counselling services and reports of student suicides in the news? And what can universities do to help? Dr Nicola Byrom, Lecturer in Psychology at King’s College London, is using UK Research and Innovation ‘Network Plus’ funding to find out.
Type ‘Student mental health’ into a search of UK news and you’ll be hit by headlines referring to: ‘The ticking time-bomb’, ‘Students being let down’, warnings that ‘problems are rising’. If you read these stories in isolation, you’d be forgiven for thinking that we’re in the depths of a crisis in student mental health.
In reality the picture is much more complex. In June this year, the Office of National Statistics reported that the suicide rate among the general population is actually higher than the comparable age group of university students.
For the past three decades, Janet Seeley, Professor of Anthropology and Health at the London School of Hygiene & Tropical Medicine, has been engaged in HIV research across Asia and sub-Saharan Africa. For the last 10 years, she has led the Social Aspects of Health Across the Lifecourse programme in the MRC/UVRI and LSHTM Uganda Research Unit. Here she tells us about some of the challenges in getting HIV testing and treatment to everyone in need.
If everyone living with HIV takes an HIV test and knows their status, and if everyone with an HIV-positive test begins antiretroviral therapy (ART) HIV treatment rapidly, this enhances their chance of living a healthy life into old age. That treatment can also reduce the amount of virus in a person’s body to such a low level that they will not pass the virus on to others.
This is universal test and treat, a strategy aimed at getting everyone who is living with HIV on to treatment and thus significantly increasing the proportion of people who are aware of their HIV status and receiving that treatment. Read more